Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.

Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Nipah virus is a highly virulent zoonotic paramyxovirus causing severe respiratory and neurological disease ... The cryo-electron microscopy L-P complex structure reveals the organization of the ...

the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like ... New Roles in Infectious Process for Molecule That Inhibits Flu ...

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV ...

One year after becoming available for older Americans and pregnant women, receptive public opinion of respiratory syncytial virus (RSV) vaccines is growing, according to the latest poll from the ...

According to the latest weekly update from the Centers for Disease Control and Prevention (CDC), COVID-19, seasonal influenza, and respiratory syncytial virus (RSV) activity continue to increase ...

Respiratory virus activity levels are rising in many parts of the country, with 24 states reporting high levels for the week ending Dec. 21, up from 14 the week prior. Eight states — Alabama ...